Phospho-RPS6 has been reported to attenuate KRAS-induced DNA damage in acinar cells and in acinar-to-ductal metaplasia (ADM) and p53-mediated tumor suppression during initiation of pancreatic cancer (63). Here, TP53 is linked to neoplasm.